9th Tumor Models San Francisco Summit 2025, January 29-30, 2025

Conference

genOway presentation

Event
-
January 22, 2025

‍

genOway's presentation on Wednesday, January 29, 2025 | 4 p.m. PST:

Assessment of translational tumor biology and efficacy in humanized mouse models

  • Outlining BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
  • Investigating human immune cell recruitment into tumor microenvironment in BRGSF-HIS mice
  • Assessment of anti-tumoral compounds in BRGSF-HIS mice
  • Use of hFcγR model to investigate the Fc-mediate effector functions of therapeutic antibodies

9th Tumor Models San Francisco Summit 2025, January 29-30, 2025

Get in touch

Let us know how we can help

Other news & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
18th annual PEGS Europe, Lisbon, Portugal, November 16-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics in Tukuba, Japan, November 16-19, 2026
Conference
Event
-
Nov 2026
Read on
SITC meeting 2026, Phoenix, Arizona, November 4-8
Conference
genOway presentation
Event
-
Nov 2026
Read on
2nd T-Cell Engager for Autoimmune Disease Summit, Boston, October 27-29, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe